These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26942872)

  • 1. APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.
    Hong SH; Lee WJ; Kim YD; Kim H; Jeon YJ; Lim B; Cho DH; Heo WD; Yang DH; Kim CY; Yang HK; Yang JK; Jung YK
    Oncotarget; 2016 Apr; 7(16):21601-17. PubMed ID: 26942872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.
    Noguchi H; Sakamoto C; Wada K; Akamatsu T; Uchida T; Tatsuguchi A; Matsui H; Fukui H; Fujimori T; Kasuga M
    Gastroenterology; 1999 Nov; 117(5):1119-27. PubMed ID: 10535875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin.
    Yoshioka T; Nishikawa Y; Ito R; Kawamata M; Doi Y; Yamamoto Y; Yoshida M; Omori Y; Kotanagi H; Masuko T; Enomoto K
    Cancer Sci; 2010 Sep; 101(9):2011-8. PubMed ID: 20626753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
    Yang C; Liu Y; Lemmon MA; Kazanietz MG
    Mol Cell Biol; 2006 Feb; 26(3):831-42. PubMed ID: 16428439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
    Awasthi S; Hamburger AW
    J Cell Physiol; 2014 Nov; 229(11):1831-41. PubMed ID: 24692179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
    Holbro T; Beerli RR; Maurer F; Koziczak M; Barbas CF; Hynes NE
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8933-8. PubMed ID: 12853564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis.
    Kawano S; Mizutani K; Miyata M; Ikeda W; Takai Y
    Genes Cells; 2010 Sep; 15(9):995-1001. PubMed ID: 20695903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
    Kawano S; Ikeda W; Kishimoto M; Ogita H; Takai Y
    J Biol Chem; 2009 Aug; 284(35):23793-805. PubMed ID: 19561085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.
    Mizutani K; Kedashiro S; Maruoka M; Ueda Y; Takai Y
    Sci Rep; 2017 Sep; 7(1):11375. PubMed ID: 28900130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.
    Xia W; Liu LH; Ho P; Spector NL
    Oncogene; 2004 Jan; 23(3):646-53. PubMed ID: 14737100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.
    Vijapurkar U; Kim MS; Koland JG
    Exp Cell Res; 2003 Apr; 284(2):291-302. PubMed ID: 12651161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells.
    Kornblum HI; Yanni DS; Easterday MC; Seroogy KB
    Dev Neurosci; 2000; 22(1-2):16-24. PubMed ID: 10657694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3.
    Sak MM; Szymanska M; Bertelsen V; Hasmann M; Madshus IH; Stang E
    Carcinogenesis; 2013 Sep; 34(9):2031-8. PubMed ID: 23698633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.